{"filing":{"accession_number":"0001193125-26-273345","cik":"0001859795","ticker":"NVNXF","company_name":"NOVONIX Ltd","form":"6-K","filing_date":"2026-06-17","report_date":null,"primary_document":"nvx-6k-june-17-26_capita.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1859795/000119312526273345/nvx-6k-june-17-26_capita.htm"},"events":[{"id":12416,"run_id":10985,"accession_number":"0001193125-26-273345","anchor_item_number":"EX-99.2","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"NOVONIX announced a material capital raising comprising an institutional placement of 129,334,163 ordinary shares at A$0.16 per share (a 31.2–33.3% discount to market prices) under ASX Listing Rule 7.1 placement capacity, together with a non-underwritten share purchase plan (SPP) offering up to 18,750,000 shares to eligible shareholders at the same price. The placement and SPP are expected to raise approximately A$23.7 million in aggregate, directed toward capital expenditure and production capacity expansion.","company_name":"NOVONIX Ltd","ticker":"NVNXF","filing_date":"2026-06-17","form":"6-K","submitted_at":null,"items":[{"id":9256,"accession_number":"0001193125-26-273345","item_number":"EX-99.1","item_title":"nvx-ex99_1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The exhibit is a request for a trading halt pending \"an announcement regarding a proposed material capital raising.\" A material capital raising by a public company typically involves dilutive equity issuance (private placement, PIPE, or public offering). The explicit reference to \"material capital raising\" and the ASX trading halt mechanism signal an imminent equity financing event that would materially affect shareholders through dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:48:15.459543+00:00","company_name":"","ticker":null,"filing_date":""},{"id":9257,"accession_number":"0001193125-26-273345","item_number":"EX-99.2","item_title":"nvx-ex99_2.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"NOVONIX announced a firm commitment for an institutional placement of A$20.7 million in fully paid ordinary shares at A$0.16 per share, representing a 31.2% discount to the 5-day VWAP and 33.3% discount to the last traded price. The company is also launching a non-underwritten share purchase plan (SPP) targeting approximately A$3.0 million. This is a dilutive equity issuance raising capital through a discounted placement to institutional investors and shareholders, with proceeds directed toward capital expenditure and production capacity expansion.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:48:15.459543+00:00","company_name":"","ticker":null,"filing_date":""},{"id":9258,"accession_number":"0001193125-26-273345","item_number":"EX-99.3","item_title":"nvx-ex99_3.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"NOVONIX is announcing a dual equity issuance: a placement of 129,334,163 ordinary shares at AUD 0.16 per share (issued under the 15% placement capacity under ASX Listing Rule 7.1 without shareholder approval) and a securities purchase plan (SPP) offering up to 18,750,000 shares to eligible shareholders at the same price. The placement represents a substantial dilution to existing shareholders and is being issued without full shareholder approval, relying on the company's placement capacity. This is a material capital-raising event that would significantly affect investor assessment of ownership dilution and the company's financing strategy.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:48:15.459543+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9256,"accession_number":"0001193125-26-273345","item_number":"EX-99.1","item_title":"nvx-ex99_1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The exhibit is a request for a trading halt pending \"an announcement regarding a proposed material capital raising.\" A material capital raising by a public company typically involves dilutive equity issuance (private placement, PIPE, or public offering). The explicit reference to \"material capital raising\" and the ASX trading halt mechanism signal an imminent equity financing event that would materially affect shareholders through dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:48:15.459543+00:00","company_name":"NOVONIX Ltd","ticker":"NVNXF","filing_date":"2026-06-17"},{"id":9257,"accession_number":"0001193125-26-273345","item_number":"EX-99.2","item_title":"nvx-ex99_2.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"NOVONIX announced a firm commitment for an institutional placement of A$20.7 million in fully paid ordinary shares at A$0.16 per share, representing a 31.2% discount to the 5-day VWAP and 33.3% discount to the last traded price. The company is also launching a non-underwritten share purchase plan (SPP) targeting approximately A$3.0 million. This is a dilutive equity issuance raising capital through a discounted placement to institutional investors and shareholders, with proceeds directed toward capital expenditure and production capacity expansion.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:48:15.459543+00:00","company_name":"NOVONIX Ltd","ticker":"NVNXF","filing_date":"2026-06-17"},{"id":9258,"accession_number":"0001193125-26-273345","item_number":"EX-99.3","item_title":"nvx-ex99_3.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"NOVONIX is announcing a dual equity issuance: a placement of 129,334,163 ordinary shares at AUD 0.16 per share (issued under the 15% placement capacity under ASX Listing Rule 7.1 without shareholder approval) and a securities purchase plan (SPP) offering up to 18,750,000 shares to eligible shareholders at the same price. The placement represents a substantial dilution to existing shareholders and is being issued without full shareholder approval, relying on the company's placement capacity. This is a material capital-raising event that would significantly affect investor assessment of ownership dilution and the company's financing strategy.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:48:15.459543+00:00","company_name":"NOVONIX Ltd","ticker":"NVNXF","filing_date":"2026-06-17"}]}